Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of LTP001 for Patients with Idiopathic Pulmonary Fibrosis
PolandStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
PolandStudy on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)
PolandStudy on the Effectiveness and Safety of Obinutuzumab and Tacrolimus for Patients with Primary Membranous Nephropathy
PolandLong-term Study of Zanubrutinib for Patients with B-cell Blood Cancer
PolandStudy Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
PolandStudy of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy
PolandLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
PolandStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
PolandStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
PolandStudy Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PolandStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
